Tower Research Capital LLC TRC Buys 15,364 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Tower Research Capital LLC TRC increased its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 72.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,514 shares of the health services provider’s stock after buying an additional 15,364 shares during the period. Tower Research Capital LLC TRC’s holdings in Teladoc Health were worth $332,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health in the 4th quarter worth $29,000. Versant Capital Management Inc raised its holdings in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Lindbrook Capital LLC lifted its position in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after buying an additional 1,612 shares during the last quarter. Sterling Capital Management LLC boosted its holdings in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after buying an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Teladoc Health in the 4th quarter worth approximately $60,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on TDOC. Evercore ISI lowered their target price on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a research note on Thursday. The Goldman Sachs Group decreased their price objective on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a report on Thursday. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Bank of America decreased their price objective on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a report on Friday, April 11th. Finally, Canaccord Genuity Group decreased their price objective on Teladoc Health from $14.00 to $12.00 and set a “buy” rating for the company in a report on Thursday. Eleven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $9.81.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.58% of the stock is owned by company insiders.

Teladoc Health Trading Down 2.9 %

Teladoc Health stock opened at $6.99 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of -1.21 and a beta of 1.73. The stock has a 50-day moving average price of $8.10 and a 200 day moving average price of $9.51.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.